SCHEMBL6806730

SCHEMBL6806730

CCc1cc(C)cc(CC)c1C(C(N)=O)C(N)=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.35
ALOX12 P18054 1/20 0.35
HTT P42858 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
EPHX1 P07099 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
TPMT P51580 1/20 0.32
PKM P14618 1/20 0.32
SRC P12931 1/20 0.32
SLC7A5 Q01650 1/20 0.32
GAA P10253 2/20 0.32
KDM4E B2RXH2 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
MAPK1 P28482 1/20 0.32
PPARG P37231 1/20 0.32
MAPK10 P53779 1/20 0.32
NCOA2 Q15596 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31318197 0.84 ALOX15 (0.37) ALOX15ALOX12HTTNPSR1EPHX1
SCHEMBL3151639 0.83 SRC (0.41) ALOX15ALOX12HTTNPSR1TPMT
SCHEMBL12774634 0.80 MMP8 (0.40) HTTCYP1A2L3MBTL1ALDH1A1MAPK1
SCHEMBL28229035 0.80 BACE1 (0.37) ALOX15HTTEPHX1PKMGAA
SCHEMBL6808060 0.79 HTT (0.43) ALOX15ALOX12HTTNPSR1CYP1A2
SCHEMBL6807015 0.79 TAS1R3 (0.40) HTTNPSR1CYP1A2SLC7A5KDM4E
SCHEMBL6807017 0.76 MMP8 (0.41) CYP1A2SRCSLC7A5KDM4EL3MBTL1
SCHEMBL6807941 0.76 KDM4E (0.42) NPSR1EPHX1TPMTGAAKDM4E
SCHEMBL580070 0.74 POLB (0.39) CYP1A2CYP3A4TPMTKDM4EL3MBTL1
SCHEMBL6808211 0.73 CCNC (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12516069-B2 Process for the preparation of pyrazole-oxadiazepine GHARDA CHEMICALS LIMITED (IN) 2026-01-06 US claimed
CN-118894786-A Preparation method of 2, 6-diethyl-4-methylphenyl malonamide 江苏七洲绿色科技研究院有限公司 2024-11-05 CN claimed
US-11993555-B2 Conjugated triene compound, and preparation and application thereof ORIENTAL(LUZHOU) AGROCHEMICALS CO., LTD. (CN) 2024-05-28 US claimed
US-20240059707-A1 PROCESS FOR THE PREPARATION OF PYRAZOLE-OXADIAZEPINE GHARDA CHEMICALS LIMITED (IN) 2024-02-22 US claimed
EP-4259611-A1 A PROCESS FOR THE PREPARATION OF PYRAZOLE-OXADIAZEPINE Gharda Chemicals Limited (IN) 2023-10-18 EP claimed
WO-2022123541-A1 A PROCESS FOR THE PREPARATION OF PYRAZOLE-OXADIAZEPINE GHARDA CHEMICALS LIMITED (IN) 2022-06-16 WO claimed
US-11345648-B2 Halogenated conjugated diene compound, and preparation and application thereof ORIENTAL(LUZHOU) AGROCHEMICALS CO., LTD. (CN) 2022-05-31 US claimed
US-20220064184-A1 METHOD FOR PREPARING 2-ARYLMALONIC ACID DERIVATIVE AND INTERMEDIATE, AND USE THEREOF ORIENTAL(LUZHOU) AGROCHEMICALS CO., LTD. (CN) 2022-03-03 US claimed
US-20220017437-A1 HALOGENATED CONJUGATED DIENE COMPOUND, AND PREPARATION AND APPLICATION THEREOF ORIENTAL(LUZHOU) AGROCHEMICALS CO., LTD. (CN) 2022-01-20 US claimed
CN-112028906-B Method for preparing pinoxaden by one-pot boiling method 东南大学 2021-10-19 CN claimed
CN-112028906-A Method for preparing pinoxaden by one-pot boiling method 东南大学 2020-12-04 CN claimed
CN-106928253-A A kind of preparation method of pinoxaden 武汉工程大学 2017-07-07 CN claimed
US-12516069-B2 Process for the preparation of pyrazole-oxadiazepine GHARDA CHEMICALS LIMITED (IN) 2026-01-06 US disclosed
US-20250313540-A1 PROCESS FOR THE PREPARATION OF [1,4,5]-OXADIAZEPINE DERIVATIVES SYNGENTA CROP PROTECTION AG (CN) 2025-10-09 US disclosed
EP-3950659-B1 METHOD FOR PREPARING 2-ARYLMALONIC ACID DERIVATIVE, INTERMEDIATE, AND APPLICATION THEREOF ORIENTAL LUZHOU AGROCHEMICALS CO LTD (CN) 2025-07-16 EP disclosed
CN-119156378-A Process for the preparation of [1,4,5] -oxadiazepine derivatives 先正达农作物保护股份公司 2024-12-17 CN disclosed
EP-1183317-B1 PROCESS FOR THE PREPARATION OF HERBICIDAL DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2003-09-17 EP disclosed
US-6552187-B1 Cyclization condensation of arylmalonic acid diamides or arylmalonic acid monoamides with hydrazine derivatives forming substituted 3-hydroxy-4-aryl-5-oxopyrazolines; high yield and purity SYNGENTA CROP PROTECTION, INC. 2003-04-22 US disclosed
EP-1183317-A2 PROCESS FOR THE PREPARATION OF HERBICIDAL DERIVATIVES Syngenta Participations AG (CH) 2002-03-06 EP disclosed
WO-2000078881-A2 PROCESS FOR THE PREPARATION OF HERBICIDAL DERIVATIVES SYGENTA PARTICIPATIONS AG (CH) 2000-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11993555-B2 Conjugated triene compound, and preparation and application thereof CYP19A1, CYP2A13, CYP2A6 ALOX15 188/4885ALOX12 119/4885HTT 2010/4885
US-20240059707-A1 PROCESS FOR THE PREPARATION OF PYRAZOLE-OXADIAZEPINE CYP3A4, OXA1L, CYP3A5 ALOX15 898/4885ALOX12 965/4885HTT 3490/4885
US-20220064184-A1 METHOD FOR PREPARING 2-ARYLMALONIC ACID DERIVATIVE AND INTERMEDIATE, AND USE THEREOF CYP2A6, CYP2B6, CYP2A13 ALOX15 479/4885ALOX12 364/4885HTT 1777/4885
US-11345648-B2 Halogenated conjugated diene compound, and preparation and application thereof CYP19A1, CYP2A6, CYP21A2 ALOX15 230/4885ALOX12 179/4885HTT 2103/4885
US-20220017437-A1 HALOGENATED CONJUGATED DIENE COMPOUND, AND PREPARATION AND APPLICATION THEREOF CYP19A1, CYP2A6, CYP21A2 ALOX15 230/4885ALOX12 179/4885HTT 2103/4885
US-20250313540-A1 PROCESS FOR THE PREPARATION OF [1,4,5]-OXADIAZEPINE DERIVATIVES ADH1C, ADH1A, ADH5 ALOX15 991/4885ALOX12 885/4885HTT 2605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.